Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography With Laparoscopic Cholecystectomy
Primary Purpose
Cholecystitis, Chronic Calculous Cholecystitis, Acute Calculous Cholecystitis
Status
Completed
Phase
Not Applicable
Locations
Egypt
Study Type
Interventional
Intervention
Indocyanine Green Fluorescent Laparoscopic Cholangiography
White Light
Sponsored by
About this trial
This is an interventional diagnostic trial for Cholecystitis focused on measuring Laparoscopic Cholecystectomy, Indocyanine Green Fluorescent Cholangiography, Indocyanine Green Fluorescent Angiography
Eligibility Criteria
Inclusion Criteria:
- adults (from 18 to 75 years old)
- suffering from a gall bladder disease
- with valid indication for laparoscopic cholecystectomy (e.g., calculus gall bladder with cholecystitis)
- accepted to participate in the study.
Exclusion Criteria:
- Patients with history of previous biliary surgery
- Patients with abdominal malignancy
- Patients with advanced chronic liver disease
- pregnant women
Sites / Locations
- Ain Shams University Hospitals - AUSH
Arms of the Study
Arm 1
Arm 2
Arm Type
Experimental
Active Comparator
Arm Label
NIR/ICG Arm
WL Arm
Arm Description
Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography will be done during the Laparoscopic Cholecystectomy
Conventional white light was used for Laparoscopic Cholecystectomy
Outcomes
Primary Outcome Measures
Visual identification of the biliary tree
To measure the % of patients in which investigators can identify visually the extra hepatic biliary system (the CD, CBD, CHD, and any possible anomalies present), during LC.
Visual identification of the cystic artery
To measure the % of patients in which investigators can identify visually the cystic artery, during LC.
Secondary Outcome Measures
Visual identification of injuries
To detect of incidence rate of biliary or vascular injury, visually or clinically, resulted from miss identification of the structures.
Compare operative time
To compare the operative time in (minutes)
Compare blood loss
To compare the operative blood loss (in cc)
Compare blood loss in cc
To compare the blood loss (in cc) between the two groups.
Percentage of patients of ICG adverse reactions
To measure % of patients suffering off reactions related to the use of ICG (by vital data assessment, monitor patients' complaints, etc..)
Full Information
NCT ID
NCT05125653
First Posted
October 4, 2021
Last Updated
November 18, 2021
Sponsor
Ain Shams University
1. Study Identification
Unique Protocol Identification Number
NCT05125653
Brief Title
Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography With Laparoscopic Cholecystectomy
Official Title
Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography With Laparoscopic Cholecystectomy, a Randomized Controlled Trial
Study Type
Interventional
2. Study Status
Record Verification Date
November 2021
Overall Recruitment Status
Completed
Study Start Date
January 1, 2020 (Actual)
Primary Completion Date
July 1, 2021 (Actual)
Study Completion Date
July 1, 2021 (Actual)
3. Sponsor/Collaborators
Responsible Party, by Official Title
Principal Investigator
Name of the Sponsor
Ain Shams University
4. Oversight
Studies a U.S. FDA-regulated Drug Product
No
Studies a U.S. FDA-regulated Device Product
No
Data Monitoring Committee
No
5. Study Description
Brief Summary
This was a double blinded, randomized, controlled trial involved patients underwent laparoscopic cholecystectomy
Detailed Description
A double blinded, randomized, controlled trial involved patients underwent laparoscopic cholecystectomy in Ain-Shams University Specialized Hospital in the period from January 2020 till July 2021. Group A (n=60) underwent laparoscopic cholecystectomy using the usual white light, Group B (n=58) underwent laparoscopic cholecystectomy with ICG florescence cholangiography and intraoperative ICG florescence arteriography.
6. Conditions and Keywords
Primary Disease or Condition Being Studied in the Trial, or the Focus of the Study
Cholecystitis, Chronic Calculous Cholecystitis, Acute Calculous Cholecystitis
Keywords
Laparoscopic Cholecystectomy, Indocyanine Green Fluorescent Cholangiography, Indocyanine Green Fluorescent Angiography
7. Study Design
Primary Purpose
Diagnostic
Study Phase
Not Applicable
Interventional Study Model
Parallel Assignment
Model Description
2 arms, randomized, double blinded
Masking
ParticipantInvestigator
Allocation
Randomized
Enrollment
118 (Actual)
8. Arms, Groups, and Interventions
Arm Title
NIR/ICG Arm
Arm Type
Experimental
Arm Description
Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography will be done during the Laparoscopic Cholecystectomy
Arm Title
WL Arm
Arm Type
Active Comparator
Arm Description
Conventional white light was used for Laparoscopic Cholecystectomy
Intervention Type
Procedure
Intervention Name(s)
Indocyanine Green Fluorescent Laparoscopic Cholangiography
Other Intervention Name(s)
Indocyanine Green Fluorescent LaparoscopicCholangiography
Intervention Description
Indocyanine Green Fluorescent Cholangiography
Intervention Type
Procedure
Intervention Name(s)
White Light
Other Intervention Name(s)
WL
Intervention Description
Performing the laparoscopic cholecystectomy and identifying the biliary structures under the conventional white light
Primary Outcome Measure Information:
Title
Visual identification of the biliary tree
Description
To measure the % of patients in which investigators can identify visually the extra hepatic biliary system (the CD, CBD, CHD, and any possible anomalies present), during LC.
Time Frame
during the procedure
Title
Visual identification of the cystic artery
Description
To measure the % of patients in which investigators can identify visually the cystic artery, during LC.
Time Frame
during the procedure
Secondary Outcome Measure Information:
Title
Visual identification of injuries
Description
To detect of incidence rate of biliary or vascular injury, visually or clinically, resulted from miss identification of the structures.
Time Frame
during and imediatly after the procedure (24 hours)
Title
Compare operative time
Description
To compare the operative time in (minutes)
Time Frame
during the procedure
Title
Compare blood loss
Description
To compare the operative blood loss (in cc)
Time Frame
during the procedure
Title
Compare blood loss in cc
Description
To compare the blood loss (in cc) between the two groups.
Time Frame
during the procedure
Title
Percentage of patients of ICG adverse reactions
Description
To measure % of patients suffering off reactions related to the use of ICG (by vital data assessment, monitor patients' complaints, etc..)
Time Frame
Within 24 hour of the procedure
10. Eligibility
Sex
All
Minimum Age & Unit of Time
18 Years
Maximum Age & Unit of Time
75 Years
Accepts Healthy Volunteers
No
Eligibility Criteria
Inclusion Criteria:
adults (from 18 to 75 years old)
suffering from a gall bladder disease
with valid indication for laparoscopic cholecystectomy (e.g., calculus gall bladder with cholecystitis)
accepted to participate in the study.
Exclusion Criteria:
Patients with history of previous biliary surgery
Patients with abdominal malignancy
Patients with advanced chronic liver disease
pregnant women
Overall Study Officials:
First Name & Middle Initial & Last Name & Degree
M Abd-erRazik, MD
Organizational Affiliation
Ain Shams University
Official's Role
Study Chair
Facility Information:
Facility Name
Ain Shams University Hospitals - AUSH
City
Cairo
Country
Egypt
12. IPD Sharing Statement
Learn more about this trial
Indocyanine Green Fluorescent Cholangiography and Intraoperative Angiography With Laparoscopic Cholecystectomy
We'll reach out to this number within 24 hrs